Trusted by 100,000+ International Patients
Immunotherapy: India vs Spain
Cost, Quality & Recovery Compared
$3000
India Starting Cost
$3109
Spain Starting Cost
See how these top medical tourism destinations compare for Immunotherapy.
| Comparison Factor | India | Spain | Winner |
|---|---|---|---|
| Average Cost (in USD) | 3000 - 5000 | 3109 - 10362 | India |
| Success Rate (Min and Max) | 20% - 80% (cancer-type and stage dependent) | 20% - 55% | India |
| Advanced Technology | Checkpoint inhibitors (PD-1/PD-L1, CTLA-4), CAR-T therapy (select centres), biomarker-based targeted immunotherapy | Checkpoint inhibitors (PD-1, PD-L1, CTLA-4 therapies), CAR-T cell therapy and adoptive cell transfer, and monoclonal antibodies and cancer vaccines | Both Equal |
| JCI Accredited Hospitals | 30+ | 10+ | India |
| Visa Process | Medical Visa 3–7 days | Medical visa (Schengen visa, 10-15 days) | Both Equal |
*Costs are estimates and may vary based on hospital, complexity, and package inclusions. See detailed cost breakdown below
Understand exactly where your money goes. Both countries offer all-inclusive packages, but here's how the costs typically break down.
Best for Budget-Conscious Patients
Offered Package Price (Additional Cost Excluded)
Best for Flexible Donor Requirements
Offered Package Price (Additional Cost Excluded)
Want a personalized cost estimate based on your specific condition?
Get Your Free QuoteBoth India and Spain maintain world-class healthcare standards with internationally accredited hospitals and highly trained medical professionals.
JCI + NABH-accredited oncology centres with advanced cancer care units
Improved survival and disease control in selected cancers with biomarker-guided immunotherapy
Cancer therapies regulated under national drug safety authorities and institutional oncology protocols
Hospitals follow EU oncology and drug safety standards. Many are JCI and ISO-certified institutions
Effective in treating lung cancer, melanoma, lymphoma, kidney, and breast cancers. Helps the immune system identify and destroy cancer cells
Regulated by the Spanish Ministry of Health. Strict adherence to EU pharmaceutical and oncology guidelines
| Quality Metric | India | Spain |
|---|---|---|
Accredited Hospitals | 30+ | 10+ |
Average Success Rate | 20%–80% (cancer-specific) | 20% - 55% |
Both countries have highly qualified and experienced medical specialists trained at premier institutions worldwide. Here's what sets them apart.
Medical Oncologist / Immunotherapy Specialist
Experienced oncology teams in high-volume cancer centres
Specialised in medical oncology and immunotherapy research. Managed by oncologists, immunologists, and multidisciplinary cancer teams
Moderate to high patient volume in leading cancer centers. Growing adoption of immunotherapy protocols across Spain
All surgeons listed on Medigence are verified for their medical license, board certifications, hospital affiliations, and patient outcomes. We conduct background checks and regularly update our database to ensure you're connected with the best medical professionals.
Beyond medical excellence, your comfort during treatment matters. Compare the patient experience at top hospitals in both destinations.
World-class hospitals, exceptional value
Major cancer centres in India offer dedicated day-care infusion units for immunotherapy, advanced diagnostic labs for biomarker testing, and multidisciplinary tumor boards. Select centres provide advanced therapies like CAR-T under specialised programs.
Luxury healthcare experience
Equipped with advanced oncology units and infusion centers. Integration with genetic labs, imaging systems, and ICUs
Plan your medical journey with confidence. Here's everything you need to know about travel, visas, and accommodation in both countries.
We provide end-to-end travel assistance including visa facilitation, airport pickups, hotel bookings near your hospital, and local support throughout your stay. Our patient coordinators handle all logistics so you can focus on recovery.
Understanding the recovery process helps you plan better. Here's what to expect after Immunotherapy in both countries.
Immunotherapy is usually given in cycles over several months.
Patients can maintain daily activities with monitoring.
A short local stay is recommended during initial cycles.
Response and recovery vary depending on the cancer type and the individual's response.
In-person follow-ups recommended at 3, 6, 12 months. Telemedicine available.
Usually, a day-care or a short hospital stay
Treatment given in cycles over weeks or months
Each session lasts a few hours (IV infusion)
Normal activities can continue with monitoring
Comprehensive telemedicine follow-up program. Return visits at 6, 12 months if possible.
Immunotherapy recipients require lifelong immunosuppressant medications. Ensure you have a plan for obtaining these medications and regular blood monitoring in your home country before traveling abroad for surgery.
Every medical procedure carries risks. We believe in complete transparency so you can make a fully informed decision about your Immunotherapy journey.
Immune system activation may cause inflammation in organs (lungs, liver, thyroid)
Fatigue is common during treatment
Possible immune-related adverse events requiring monitoring
Rare but serious complications if immune reactions are severe
Supportive medications may cause mild side effects
The right choice depends on your specific situation. Here's a clear guide to help you decide which destination aligns with your needs.
Patients with cancers such as lung cancer, melanoma, kidney cancer, or lymphoma where immunotherapy is indicated. Suitable for those who meet biomarker criteria and can undergo multiple treatment cycles.
Patients with cancers such as lung cancer, melanoma, kidney cancer, or lymphoma, for whom immunotherapy is indicated. Suitable for those who meet biomarker criteria and can undergo multiple treatment cycles.
Our medical tourism experts can analyze your case and recommend the best destination based on your medical history and budget.
Follow this step-by-step framework to make the right choice for your Immunotherapy journey.
Consult a medical oncologist to determine eligibility for immunotherapy
Costs depend on drug type, number of cycles, and testing requirements
Treatment is given in cycles; plan travel accordingly
Provide biopsy reports, imaging, and previous treatment details
Regular monitoring and follow-ups are essential during therapy
Let our medical tourism experts guide you through the process. We'll help you:
No obligation • Free consultation • Response within 24 hours
Surgical Oncologist
15 Years of Experience
Dr. Prateek Varshney is a renowned Surgical Oncologist. He has experience of more than 15+ years in surgical Oncology. He is currently practicing as a consultant at Metro Mass Hospital and Cancer Institute. He was also previously associated as a consultant with Sir Ganga Ram Hospital and as a professor at Gujarat Cancer Research Institute. View More
Last Reviewed - January 2026